|
?:abstract
|
-
ABSTRACT Objective: To study the HRCT chest findings in patients undergoing cardiac interventions during COVID-19 era Study Design: Cross sectional analytical study Place and Duration of Study: Armed Forces Institute of Cardiology and National Institute of Heart Disease (AFIC/NIHD) Rawalpindi, from Apr 2020 to May 2020 Methodology: All the admitted cardiac patients who were to undergo any invasive cardiac intervention underwent plain HRCT chest and polymerase chain Reaction (PCR) for SARS-CoV-2 simultaneously One hundred and ten patients were studied We analyzed preexisting respiratory illnesses, clinical, echocardiographic and radiological features Data recording, storage, assessment and analysis was done by using SPSS-21 Results: Our study included 110 patients (87 Male, 23 Female, median age 52 Years) Common reasons for admission were coronary angiography 43 (39 1%), acute Left Ventricular Failure (LVF) 30 (27 3%), Percutaneous Coronary Intervention (PCI) 13 (11 8%) and chest pain evaluation 10 (9 1%) Cardiomegaly (29 1%) followed by consolidation (9 1%) were commonest radiological finding Two third patients had abnormal HRCT chest but only few had radiological findings either suspicious (6 4%) or indeterminate (11 8%) for COVID-19 Respiratoy symptoms, positive PCR for COVID-19 and severe Left ventricular dysfunctions were correlated with abnormal HRCT findings, correlation being statistically significant (p-value 0 05) Conclusion: HRCT chest is a non-invasive and highly sensitive imaging modality, which can rapidly help in identifying, and isolating suspected cases of novel corona virus as well as in diagnosing unknown pre-existing lung diseases in cardiac patients
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}